Litigation Details for BAUSCH HEALTH IRELAND LIMITED v. LUPIN LTD. (D.N.J. 2020)
✉ Email this page to a colleague
BAUSCH HEALTH IRELAND LIMITED v. LUPIN LTD. (D.N.J. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-08-21 |
| Court | District Court, D. New Jersey | Date Terminated | 2021-03-30 |
| Cause | 35:271 Patent Infringement | Assigned To | Renee Marie Bumb |
| Jury Demand | None | Referred To | Karen M. Williams |
| Patents | 10,016,504; 8,999,313; 9,326,969; 9,592,252; 9,707,297 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BAUSCH HEALTH IRELAND LIMITED v. LUPIN LTD.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for BAUSCH HEALTH IRELAND LIMITED v. LUPIN LTD. (D.N.J. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2020-08-21 | 1 | Complaint | with U.S. Patent Nos. 8,999,313 B2; 9,326,969 B2; 9,592,252 B2; 9,707,297 B2; and 10,016,504 B2, which…United States Patent No. 10,646,512 B2 (“the ʼ512 patent”) arising under the United States patent laws, Title… THE PATENT IN SUIT 34. The U.S. Patent and Trademark Office issued the ’512 patent on May…Norgine is the assignee of the ’512 patent. A copy of the ’512 patent is attached hereto as Exhibit A. …related to claims 1–16 of the ’512 patent. 43. The ’512 patent is listed in the Orange Book in | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
